From GWAS To the Clinic: Genome-Editing the Human BCL11A Erythroid Enhancer for Fetal Globin Elevation in the Hemoglobinopathies

被引:0
|
作者
Reik, Andreas [1 ]
Chang, Kai-Hsin [2 ]
Vierstra, Jeff [2 ]
Psatha, Nikoletta [2 ]
Stehling-Sun, Sandra [2 ]
Zhou, Yuanyue [1 ]
O'Neil, Colleen M. [1 ]
Mich, Andrea [1 ]
Miller, Jeffrey C. [1 ]
Lee, Gary [1 ]
Tan, Siyuan [3 ]
Jiang, Haiyan [3 ]
Stamatoyannopoulos, George [2 ]
Papayannopoulou, Thalia [2 ]
Rebar, Edward J. [1 ]
Gregory, Philip D. [1 ]
Stamatoyannopoulos, John A. [2 ]
Urnov, Fyodor D. [1 ]
机构
[1] Sangamo BioSci Inc, Richmond, CA USA
[2] Univ Washington, Seattle, WA 98195 USA
[3] Biogen Idec Inc, Cambridge, MA USA
关键词
D O I
10.1016/S1525-0016(16)33658-9
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
53
引用
收藏
页码:S23 / S24
页数:2
相关论文
共 36 条
  • [31] Simvastatin and t-butylhydroquinone suppress KLF1 and BCL11A gene expression and additively increase fetal hemoglobin in primary human erythroid cells
    Macari, Elizabeth R.
    Schaeffer, Emily K.
    West, Rachel J.
    Lowrey, Christopher H.
    BLOOD, 2013, 121 (05) : 830 - 839
  • [32] SCF-mediated γ-globin gene expression in adult human erythroid cells is associated with KLF1, BCL11A and SOX6 down-regulation
    Lulli, Valentina
    Romania, Paolo
    Morsilli, Ornella
    Ilari, Ramona
    Gabbianelli, Marco
    Testa, Ugo
    Marziali, Giovanna
    BLOOD CELLS MOLECULES AND DISEASES, 2015, 54 (01) : 1 - 3
  • [33] Ex Vivo Gene-Edited Cell Therapy for Sickle Cell Disease: Disruption of the BCL11A Erythroid Enhancer with Zinc Finger Nucleases Increases Fetal Hemoglobin in Plerixafor Mobilized Human CD34+Cells
    Moran, Kevin
    Ling, Hui
    Lessard, Samuel
    Vieira, Benjamin
    Vu Hong
    Holmes, Michael C.
    Reik, Andreas
    Dang, Denny
    Gray, David
    Levasseur, Dana
    Rimmele, Pauline
    BLOOD, 2018, 132
  • [34] Multiplex CRISPR/Cas9 Genome Editing Targeting the BCL11A/HBG Axis Maximizes Fetal Hemoglobin Reinduction but Generates Chromosomal Translocations Which Persist In Vivo
    Samuelson, Clare
    Humbert, Olivier
    Radtke, Stefan
    Zhu, Haiying
    Llewellyn, Mallory J.
    Fields, Emily
    Cook, Savannah
    Huang, Meei-Li W.
    Negre, Olivier
    Jerome, Keith
    Kiem, Hans-Peter
    BLOOD, 2020, 136
  • [35] Clonal Analysis of Human Bone Marrow CD34+Cells Edited By BCL11A-Targeting Zinc Finger Nucleases Reveals Clinically Relevant Levels of Fetal Globin Expression in Edited Erythroid Progeny
    Chang, Kai-Hsin
    Sullivan, Timothy
    Liu, Mei
    Yang, Xiao
    Sun, Chao
    Vieira, Benjamin
    Zhang, Ming
    Long, Vu P.
    Chen, Kai
    Smith, Sarah
    Tan, Siyuan
    Reik, Andreas
    Urnov, Fyodor U.
    Rebar, Edward J.
    Danos, Olivier
    Jiang, Haiyan
    BLOOD, 2015, 126 (23)
  • [36] Induction of Fetal Hemoglobin and Reduction of Clinical Manifestations in Patients with Severe Sickle Cell Disease Treated with Shmir-Based Lentiviral Gene Therapy for Post-Transcriptional Gene Editing of BCL11A: Updated Results from Pilot and Feasibility Trial
    Esrick, Erica B.
    Federico, Amy
    Abriss, Daniela
    Armant, Myriam
    Boardman, Kari
    Brendel, Christian
    Ciuculescu, Marioara-Felicia
    Daley, Heather
    Dansereau, Colleen
    Fernandes, Augustine
    Heeney, Matthew M.
    Justus, David G.
    Kao, Pei-Chi
    Kim, Annette S.
    Kohn, Donald B.
    Lehmann, Leslie E.
    Liu, Donghui
    London, Wendy B.
    Manis, John P.
    Moore, Theodore B.
    Morris, Emily
    Pellin, Danilo
    Proeung, Ellen
    Richard, Shanna
    Roach, Gavin D.
    Shaw, Kit L.
    Terrazas, Dayna
    White, Shanna L.
    Williams, David A.
    BLOOD, 2022, 140 : 10665 - 10667